Blog
Wegovy Pill vs Foundayo: Which Oral Weight Loss Medication Is Right for You?
For people who would rather avoid weekly injections, the arrival of oral GLP-1 medicines is a genuinely exciting development. Two names now sit at the centre of that conversation: the oral tablet form of semaglutide, often referred to as the Wegovy pill, and Foundayo, the newly authorised tablet form of orforglipron. Both are taken by mouth rather than injected, but they are built differently, work slightly differently in practice, and sit at different points in their journey to UK patients.
This guide compares the two side by side, so you can understand what sets them apart before discussing your options with a pharmacist.
REX Pharmacy always recommends a full consultation before starting any weight management treatment, and that is especially true while newer options like these are still becoming established in the UK.
Quick Answer
The Wegovy pill and Foundayo are both oral GLP-1 medicines, but they are built from different types of molecule, which is why their dosing rules differ so much. The Wegovy pill generally needs to be taken on an empty stomach with a strict waiting period before food or drink, while Foundayo can be taken at any time of day with no food or water restrictions. Foundayo was authorised in the UK in August 2026, but is not yet available on the NHS, while the Wegovy pill was approved in June 2026, with supply rolling out across local pharmacies.
- Both are once-daily oral tablets, not injections
- Foundayo has no food or water restrictions; the Wegovy pill does
- Foundayo is authorised for both weight management and type 2 diabetes
- Neither should be assumed to be freely available without checking current UK availability first
Meet the Two Tablets
The Wegovy pill is an oral tablet form of semaglutide, the same active ingredient used in the injectable Wegovy and, at lower doses, in Ozempic and Rybelsus for diabetes. It was developed to offer a needle-free alternative for people who want the benefits of semaglutide without a weekly injection.
Foundayo is the brand name for orforglipron, authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) on 10 August 2026, making the UK the first country in Europe to approve it. It is manufactured by Eli Lilly, the same company behind Mounjaro, although the two are different medicines.
How They Work: A Key Scientific Difference
Both medicines belong to the GLP-1 receptor agonist class, meaning they mimic a hormone your gut naturally releases after eating, which helps you feel fuller for longer and reduces appetite. However, the two molecules are built quite differently, and this is the main reason their dosing instructions are so different.
Semaglutide is a peptide, a molecule built from a chain of amino acids. Peptides are naturally broken down by stomach acid and digestive enzymes, which normally makes them very difficult to take as a tablet. To get around this, the oral form of semaglutide is combined with an absorption enhancer and needs to be taken on a completely empty stomach, with only a small amount of water, followed by a waiting period before eating, drinking, or taking other oral medicines. This gives the tablet a brief window to be absorbed before normal digestion and food interfere with it.
Orforglipron, the active ingredient in Foundayo, is a different type of molecule, a small, non-peptide compound. Because it is not broken down by digestive enzymes in the same way that peptides are, it does not need the same strict fasting conditions to be absorbed effectively. This is the underlying reason Foundayo can be taken at any time of day, with no food or water restrictions, while the Wegovy pill cannot.
Dosing and Administration: Side-by-Side
| Feature | Wegovy Pill (Oral Semaglutide) | Foundayo (Orforglipron) |
|---|---|---|
| Molecule type | Peptide, with absorption enhancer | Small, non-peptide molecule |
| Manufacturer | Novo Nordisk | Eli Lilly |
| Frequency | Once daily | Once daily |
| Timing | On an empty stomach, first thing, with a small amount of water | Any time of day |
| Food/water restrictions | Must wait at least 30 minutes before eating, drinking, or taking other oral medicines | None specified |
| Dose escalation | Gradual increase over several weeks | Starts at 0.8mg, increasing through 2.5mg, 5.5mg, 9mg, 14.5mg, up to 17.2mg, with a minimum of one month at each level |
| Authorised uses | Weight management | Weight management and type 2 diabetes |
| UK availability | Variable, confirm current status with our pharmacists | Authorised, but not yet available via the NHS |
Weight Loss and Efficacy Data
Because these two medicines have been studied in separate clinical trial programmes, using different populations and methods, it is important not to treat published figures as a direct head-to-head comparison. Oral semaglutide for weight management has been studied in trials sometimes referred to as the OASIS programme, which has reported meaningful average weight loss at higher tested doses. Full UK-specific efficacy data for Foundayo should be reviewed through official sources as more detail is published following its recent authorisation, including the MHRA’s announcement.
As with any comparison across separate trials, individual results vary considerably, and neither set of figures guarantees a particular outcome for any one person.
Side Effects: What to Expect From Either Option
Because both medicines work on the same GLP-1 pathway, their side effect profiles are broadly similar, centred on the digestive system.
- Wegovy pill: nausea, diarrhoea, constipation, vomiting, and abdominal discomfort are among the most commonly reported effects, often most noticeable during dose increases
- Foundayo: nausea, constipation, diarrhoea, vomiting, indigestion, and abdominal pain have been identified as common side effects in its authorisation information
For either medicine, side effects tend to be most noticeable early in treatment and around dose changes, and often settle as the body adjusts. Anyone prescribed either medicine in future should follow the specific guidance in their Patient Information Leaflet and speak to a pharmacist about managing any symptoms.
Which One Might Suit You Better?
Since Foundayo is not yet available for prescription, this is currently a more theoretical comparison for most people, but it is still worth understanding the practical differences for when both may become genuine options.
- If a strict daily routine works well for you: the Wegovy pill’s empty-stomach requirement may not be a problem, particularly if you already have a consistent morning routine
- If flexibility matters more to you: Foundayo’s lack of food and water restrictions may make it easier to fit around a less predictable schedule
- If you also have type 2 diabetes: Foundayo’s authorisation covers both weight management and diabetes, whereas the Wegovy brand is specifically for weight management, with semaglutide’s diabetes indication marketed under different brand names
- If you want to start treatment as soon as possible: current UK availability will be the deciding factor rather than personal preference, since Foundayo is not yet accessible for prescription
Speak to our team via our contact page if you would like a personalised assessment of which currently available treatment might suit you best.
Frequently Asked Questions
Is Foundayo just a version of Wegovy in tablet form?
No. Foundayo (orforglipron) and the Wegovy pill (oral semaglutide) are different active ingredients, made by different manufacturers, with different molecular structures. They belong to the same broader medicine class but are not the same drug.
Which is easier to take day to day?
Foundayo currently has no specified food or water restrictions, which may make it more flexible for daily routines, whereas the Wegovy pill requires a strict empty-stomach timing routine.
Can I get either of these on the NHS?
Foundayo is not currently available on the NHS. Wegovy pill availability, including any NHS pathway, can vary and should be checked directly with a pharmacist or GP.
Are the side effects very different between the two?
Not significantly. Both are associated primarily with digestive side effects such as nausea, diarrhoea, and constipation, since they work on the same underlying hormone pathway.
What should I do if I want to start a weight loss medication now?
Speak to a pharmacist about currently available and prescribable options, such as Mounjaro or the injectable form of Wegovy, while newer oral options continue to become established in the UK.
Accessible GLP-1 Treatment in Rotherham
Both the Wegovy pill and Foundayo represent real progress in making GLP-1 treatment more accessible to people who prefer tablets over injections, but they are not interchangeable, and their real-world availability differs considerably at the moment. Understanding how each medicine works, and being realistic about what is actually accessible today, is the best starting point for making an informed decision alongside your pharmacist.
You can also get in touch with us if you have any questions before booking.
